P38MAPK (Ab-182) antibody detects endogenous levels of total P38MAPK protein.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized non-phosphopeptide derived from human P38MAPK around the phosphorylation site of tyrosine 182 (T-G-YP-V-A).
MAPK14
Reactivity: Human
WB, IHC, IF, IP
Host: Rabbit
Polyclonal
unconjugated
Application Notes
WB: 1:500~1:1000.
Restrictions
For Research Use only
Format
Liquid
Concentration
100ug/100ul.
Buffer
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Zheng, Reynolds, Jo, Wersto, Han, Xiao: "Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 19, Issue 1, pp. 109-11, (2005) (PubMed).
van den Blink, Juffermans, ten Hove, Schultz, van Deventer, van der Poll, Peppelenbosch: "p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 166, Issue 1, pp. 582-7, (2001) (PubMed).
Target
MAPK14
(Mitogen-Activated Protein Kinase 14 (MAPK14))